A study suggests the hexavalent vaccine could enhance India's immunisation efficiency by reducing injections and easing ...

A study appearing in Human Vaccines & Immunotherapeutics found that introducing the hexavalent (six-in-one) vaccine into India's Universal Immunization Program (UIP) could improve the efficiency of ...

2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement ...

Qdenga, cleared this week for ages 4 to 60, is one of only a few dengue vaccines in the world. It is to be injected in two doses three months apart.

Dengue vaccine Qdenga is likely to be arrive in India early next year. Is this a new vaccine? Can it stop outbreaks? Who can take it? What are side effects? Here's all you need to know about Qdenga.

The Punjab Government has launched a comprehensive vaccination campaign across the district to protect cows from Lumpy Skin Disease (LSD), with the Animal Husbandry Department providing vaccination ...

India approves Takeda's QDENGA dengue vaccine for ages 4-60, offering protection against all virus serotypes without prior screening.

India approves its first dengue vaccine, Takeda's Qdenga, effective against all four dengue strains and usable without pre-vaccination screening, aiming to combat rising dengue cases nationwide.

Takeda's dengue vaccine may show up on certain dengue fever panels. But knowing when this is normal and when it is related to ...

India has approved its first dengue vaccine, QDENGA, for people aged 4 to 60 years. Know who can receive it, how the two-dose vaccine works, why it does not require pre-vaccination screening and what ...

QDENGA can be administered to individuals irrespective of previous dengue exposure, without requiring pre-vaccination testing.

While the indigenous malaria vaccine, AdFalciVax, is under evaluation, a dengue vaccine is currently in Phase 3 trials with final results expected by the end of next year.